Article Figures & Data
Tables
Type No. of Procedures (% of Total) P Value Day 1 (n = 68) Day 2 (n = 68) Day 3 (n = 136) Major adverse effect 0 (0) 0 (0) 0 (0) Local bleeding 0 (0) 0 (0) 0 (0) Local infection 0 (0) 0 (0) 0 (0) Seizures 0 (0) 0 (0) 0 (0) Acute radiation injury 0 (0) 0 (0) 0 (0) Minor adverse effect 28 (41.2) 26 (38.2) 54 (39.7) P = .730 Subdural injection 5 (7.4) 4 (5.9) 9 (6.6) P = .753 Pain 21 (30.9) 16 (23.5) 37 (27.2) P = .335 Nausea 5 (7.4) 6 (8.8) 11 (8.1) P = .753 Transient neurologic effect 3 (4.4) 4 (5.9) 7 (5.1) P = .698 - Table 2:
Volume of injectate in patients experiencing transient neurologic adverse effects
Patient Day 1 Volume (mL) Day 2 Volume (mL) Symptom/Sign A 20 31a Syncope B 33 41a Autonomic disturbance C 26 41a Altered mental status D 21 41a Autonomic disturbance E 27a 52 Syncope F 61a 31 Vertigo G 43a 33 Altered mental status ↵a Occurrence of transient neurologic adverse effects.
Jump to section
Related Articles
Cited By...
- Clinical and imaging outcomes of 100 patients with cerebrospinal fluid-venous fistulas treated by transvenous embolization
- Spinal CSF Leaks: The Neuroradiologist Transforming Care
- Temporal Characteristics of CSF-Venous Fistulas on Dynamic Decubitus CT Myelography: A Retrospective Multi-Institution Cohort Study
- Same-Day Bilateral Decubitus CT Myelography for Detecting CSF-Venous Fistulas in Spontaneous Intracranial Hypotension